1. 4320Predictive value of VTE-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with venous thromboembolism: results of the XALIA study. (28th August 2018) Authors: Klok, F A; Barco, S; Turpie, A G G; Haas, S; Kreutz, R; Mantovani, L G; Gebel, M; Monje, D; Brugge, J B; Bach, M; Konstantinides, S V; Ageno, W Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai‐VTE study. (20th July 2018) Authors: Scheres, LJJ; Brekelmans, MPA; Ageno, W; Ay, C; Büller, HR; Eichinger, S; Hutten, BA; Klok, FA; Middeldorp, S; Schreiber, K; Stach, K; Blondon, M; Delluc, A Journal: BJOG Issue: Volume 125:Number 12(2018) Page Start: 1581 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗